A possible explanation is a secondary function of ASL, as it has been shown to influence cyclin A2 levels by direct binding in hepatocellular carcinoma, independent of its enzymatic activity within the ASS1-ASL node that also promoted anchorage-independent growth56. The gene discussed is ASL; the disease is hepatocellular carcinoma.